Regional News
Don't miss our other news sources!
- AAIPharma Raises $30 Million through Rights Offering
- Hosted Solutions Acquires Boston Datacenters, Inc.
- N.C. Biotechnology Center Launches New Grant Program
- Inspire Expands Allergy Product Portfolio with Phase 3 Compound
- Argos Therapeutics Awarded NIH Contract to Further Develop HIV Immunotherapy Candidates
- Covelight Systems and Digital Resolve Form Strategic Alliance
- Peak 10 Renews Agreement with LendingTree
- Announcing the Establishment of the North Carolina Association for Advanced Learning Technology (NCALTA)
AAIPharma Raises $30 Million through Rights Offering
Chapel Hill-based AAIPharma Inc. (www.aaipharma.com)
has raised $30 million by way of a rights offering to existing
shareholders and option holders. The offering was backstopped
by a group of principal shareholders led by JPMorgan. The
proceeds will be used to accelerate and enhance the development
and growth of the company’s core service business.
AAIPharma Inc. is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. From a single test through a range of integrated service offerings, we create value to an industry in search of productivity and innovation.
AAIPharma is a CED member.
Hosted Solutions Acquires Boston Datacenters,
Inc.
Raleigh-based Hosted Solutions (www.hostedsolutions.com),
a provider of managed hosting and data center services,
has acquisition Boston Datacenters, Inc. The acquisition
will bring one of the fastest growing East Coast managed
service providers into the Boston area and will provide
New England companies with one of the only facilities able
to handle the power and cooling needs of a wide range of
companies.
Hosted Solutions also runs three SAS 70 Type II certified data centers located in Charlotte, Cary and Raleigh. Not only will the company provide managed hosting and collocation services to Boston Datacenter customers, but Hosted Solutions will also offer dedicated servers, managed storage, managed load balancing, business continuity and managed security services. The technical infrastructure of the Boston location will be interconnected with Hosted Solutions’ North Carolina sites at the network core.
Hosted Solutions is a CED member.
N.C. Biotechnology Center Launches
New Grant Program
The RTP-based North Carolina Biotechnology Center (www.ncbiotech.org),
the world's first government-sponsored organization dedicated
to developing the biotechnology industry, has announced
a new grant program that will provide up to $75,000 in individual
grants to universities and non-profit institutes throughout
the state. The program is designed to help bioscience researchers
in the state to “kick-start” their work.
The purpose of grant revenue is to help generate preliminary data that will attract investors with the ultimate goal of commercializing their technology. Biotechnology Research Grants are available to principal investigators at any North Carolina academic or nonprofit research institution, except those at the main campuses of Duke University, North Carolina State University and the University of North Carolina-Chapel Hill.
The North Carolina Biotech Center is a CED member.
Inspire Expands Allergy Product Portfolio with
Phase 3 Compound
Durham-based Inspire Pharmaceuticals, Inc. (www.inspirepharm.com)
and FAES Farma, S.A. has signed a licensing agreement for
the U.S. and Canadian development and commercialization
of bilastine, a Phase 3 oral antihistamine compound for
the treatment or prevention of allergic rhinitis, a condition
affecting approximately 40 million people in the United
States. Under the terms of the agreement, Inspire has acquired
exclusive rights to further develop and commercialize oral
formulations of bilastine in the United States and Canada,
as well as the exclusive right to develop and commercialize
the ocular formulation in various markets worldwide.
The agreement provides that Inspire will pay FAES an upfront license fee of $7 million and up to an additional $82 million of payments, contingent upon achievement of various development, regulatory and sales milestones. Inspire will also pay a royalty of 14-16% on net sales of the oral formulations of bilastine in the United States and Canada, if approved by regulatory authorities.
Inspire Pharmaceuticals is a CED member.
Argos Therapeutics Awarded NIH
Contract to Further Develop HIV Immunotherapy Candidates
Durham-based Argos Therapeutics (www.argostherapeutics.com),
a private biotechnology company, was awarded a $21 million
contract to develop novel HIV immunotherapy candidates from
the National Institutes of Health. Personalized, RNA-loaded
dendritic cell immunotherapy products designed to train
the patient’s immune system to target and destroy unique
features of their disease are being developed by Argos.
The goal of the multi-million dollar contract is to determine the immunogenicity of Argos’ HIV immunotherapy candidate, currently in clinical trials, and subsequently develop even more potent next-generation product candidates.
Argos Therapeutics is a CED member.
Covelight Systems and Digital Resolve Form Strategic
Alliance
Cary-based Covelight Systems (www.covelight.com),
a provider of actionable user information, and Digital Resolve
have entered into a strategic partnership providing financial
services institutions with the industry’s most non-intrusive
solution for fraud detection and user authentication. With
this combined approach, financial services organizations
will have a crystal clear picture of both current and previous
online user behavior, enabling the highest level of fraud
prevention for online transactions.
The technological partnership combines Covelight’s Inflight online monitoring solution with Digital Resolve’s Fraud Analyst risk-based authentication platform to deliver the most in-depth, yet non-intrusive, solution for real-time fraud detection and user authentication. The combination offers benefits such as proven, enterprise-wide threat detection capabilities in real-time, non-invasive deployment and preservation of the normal user experience.
Covelight Systems is a CED member.
Peak 10 Renews Agreement with LendingTree
Charlotte-based Peak 10 (www.peak10.com),
a data center operator and managed services provider, has
renewed its service agreement with LendingTree, LLC. The
leading independent data center operator and managed services
company will continue to host the LendingTree online lending
exchange out of its data center in Charlotte.
Since inception, LendingTree has facilitated more than 20 million loan requests and $152 billion in closed loan transactions. Peak 10 provides data center services that improve reliability, lower costs, and maximize internal resources while keeping an organization’s valuable information technology assets close to the business.
Peak 10 is a CED member.
Announcing the Establishment of the North Carolina
Association for Advanced Learning Technology (NCALTA)
North Carolina educators, scientists and business executives
have joined together to provide thought leadership and collaboration
in this area through the formation of a new organization
known as the North Carolina Association for Advanced Learning
Technologies (NCALTA). NCALTA will provide a vital network
and bridge between educators, legislators and technology
developers regarding the use and creation of Advanced Learning
Technologies.
NCALTA aims to advance research and multidisciplinary collaboration on the innovative paradigms, architectures and implementations of learning systems for adaptive learning related to STEM education (science, technology, engineering, and mathematics), mobile learning, life-long learning, just-in-time, and on-demand learning.
| 10/16 | Member-only Backyard Barbeque |
|---|---|
| 10/28 | Entrepreneurs Only Workshop™: Start-Up to Public - The Targacept Story |